Crinetics Topline Results from Paltusotine Phase 3 PATHFNDR-1 Study


September 11, 2023

Crinetics will host a conference call and webcast on Monday, September 11, 2023 at 8:00 a.m. ET to discuss the topline results from the Phase 3 PATHFNDR-1 study (NCT04837040) released on Sunday, September 10, 2023.